Physician profile
Sandy D Johns
NPI 1578908091
$1,192.19
in general payments reported to CMS, 2019-2025
16 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $366 · 2022: $208 · 2023: $288 · 2024: $203 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $451 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $450.86 |
| Education | $167.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $367.03 | 2022-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $244.79 | 2021-2025 | |
| Exeltis, USA INC. | $195.85 | 2021-2023 | Slynd |
| Mayne Pharma Commercial LLC | $101.68 | 2021-2025 | |
| Sage Therapeutics, LLC | $73.52 | 2021-2025 | Zurzuvae |
| Shield Therapeutics INC | $47.50 | 2023-2024 | Accrufer |
| Genzyme Corporation | $20.12 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $20.11 | 2025 | |
| Hologic Sales and Service, LLC | $18.75 | 2022 | |
| Roche Diagnostics Corporation | $17.55 | 2021 | |
| Sumitomo Pharma America, INC. | $15.82 | 2024 | Gemtesa |
| Supernus Pharmaceuticals, INC. | $14.93 | 2025 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $14.91 | 2021 | |
| Merck Sharp & Dohme LLC | $14.47 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.09 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $11.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandy Johns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.